Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Nasopharyngeal Carcinoma 7 Colorectal Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Recurrence 2 Neoplasms 2 Head and Neck Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Solid Tumors 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphoma, T-Cell 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1

Interventions

Cyclophosphamide 32 Etoposide 18 romidepsin 17 fludarabine 17 Vincristine 17 Doxorubicin 16 Rituximab 14 Prednisone 14 Melphalan 14 Gemcitabine 13 Brentuximab Vedotin 13 Lenalidomide 12 Peripheral Blood Stem Cell Transplantation 11 Cytarabine 11 Whole-Body Irradiation 10 Biopsy 10 10-propargyl-10-deazaaminopterin 10 pembrolizumab 9 fludarabine phosphate 9 Specimen Handling 9 Busulfan 9 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Depsipeptides 8 Carmustine 8 Bortezomib 8 duvelisib 7 Vorinostat 7 Methotrexate 7 Magnetic Resonance Spectroscopy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Endostatins × Clear all

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡